Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease

Ankylosing spondylitis (AS) is associated with an increase in cardiovascular (CV) morbidity when compared to the general population. The increased risk of CV involvement in AS is likely multifactorial including inflammation accelerating atherosclerosis and the cardiac inflammation itself in the form...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2022-06, Vol.14 (6), p.e25633-e25633
Main Authors: Bhattad, Pradnya Brijmohan, Kulkarni, Mugdha, Patel, Parasbhai D, Roumia, Mazen
Format: Article
Language:English
Subjects:
Age
Atherosclerosis
Back pain
Blood vessels
Body mass index
Cardiology
Cerebrovascular disease
Cholesterol
Cytokines
Endothelium
High density lipoprotein
Inflammation
Internal Medicine
Metabolic syndrome
Morbidity
Mortality
Patients
Psoriatic arthritis
Rheumatology
Risk factors
TNF inhibitors
Tumor necrosis factor-TNF
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ankylosing spondylitis (AS) is associated with an increase in cardiovascular (CV) morbidity when compared to the general population. The increased risk of CV involvement in AS is likely multifactorial including inflammation accelerating atherosclerosis and the cardiac inflammation itself in the form of aortitis and conduction anomalies. Establishing indisputable evidence linking AS and CV disease is challenging due to AS being relatively rare and it affects 1:1,000 and all studies analyzing the association between AS and CV disease involve a small sample size making long-term outcome measurements limited. The article reviews the literature studying the association between AS and CV disease as well as the impact of therapies for AS on the CV system (CVS).
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.25633